Oncology

Liver disease and patient advocacy in Taiwan: Q&A with Prof Yang Pei-Ming

Liver disease and patient advocacy in Taiwan: Q&A with Prof Yang Pei-Ming

Liver disease is a serious public health issue in Taiwan. In a population of over 23 million, roughly 15%–20% of adults are hepatitis B viral (HBV) carriers, and 2%–5% are infected with hepatitis C virus (HCV) [1]. To address these challenges, Taiwan’s healthcare community has shown a strong commitment to fighting viral hepatitis, improving outcomes […]

Liver disease and patient advocacy in Taiwan: Q&A with Prof Yang Pei-Ming Read More »

Liver cancer in Japan: Dr Shun Kaneko on HCC screening and surveillance

Liver cancer in Japan: Dr Shun Kaneko on HCC screening and surveillance

Japan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection leading to positive patient outcomes (62% of HCC patients are diagnosed at stage A and B [1] leading to 5-year overall survival rates as high as 44%). Japan’s medical care, health policy and health insurance offerings

Liver cancer in Japan: Dr Shun Kaneko on HCC screening and surveillance Read More »

HCC in Thailand: Dr Terachai Songkiatkawin on improving liver cancer diagnostics and treatment

Songkiatkawin_Terachai

In 2020, data from Globocan showed that more than 27,000 patients in Thailand are found to have liver cancer each year, making it the most-frequently diagnosed cancer in the country [1]. Due to gaps in surveillance, diagnostic and treatment services, many patients only discover their condition at advanced stages when the only available option is

HCC in Thailand: Dr Terachai Songkiatkawin on improving liver cancer diagnostics and treatment Read More »

HPV screening and vaccination in Asia: overcoming barriers to access

HPV screening and vaccination in Asia: overcoming barriers to access

Cervical cancer is the 4th leading type of cancer amongst women in the world. Caused by human papillomavirus (HPV) infection, cervical cancer is highly preventable through the use of prophylactic measures like HPV vaccines and robust screening programmes. Through the launch of the Global Strategy to Accelerate the Elimination of Cervical Cancer in late 2020,

HPV screening and vaccination in Asia: overcoming barriers to access Read More »

Liver disease in Asia Pacific: insights from Prof Pierce Chow

Liver disease in Asia Pacific: Q&A with Prof Pierce Chow

In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical management of common liver diseases like HBV, HCV, fatty liver and HCC; and the critical role of diagnostics in ensuring early detection and effective treatment. [00:09] – Prof Chow’s

Liver disease in Asia Pacific: insights from Prof Pierce Chow Read More »

Molecular tumour boards in Asia: turning NGS data into actionable cancer plans

Molecular tumour boards in Asia: turning NGS data into actionable cancer plans

This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list.  Across the Asia Pacific region, growing use of next-generation sequencing (NGS) in clinical laboratories is driving major

Molecular tumour boards in Asia: turning NGS data into actionable cancer plans Read More »

NGS and precision oncology in Taiwan: insights from Dr Jan-Gowth Chang and Dr Jason CH Hsieh

NGS and precision oncology in Taiwan: insights from Dr Jan-Gowth Chang and Dr Jason CH Hsieh

This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list. In 2020, Taiwan’s National Development Council forecasted that its people would reach ‘super-aged’ status by 2025. Since

NGS and precision oncology in Taiwan: insights from Dr Jan-Gowth Chang and Dr Jason CH Hsieh Read More »

NGS and precision oncology in Australia: insights from Profs Peter Gibbs and Svetlana Cherepanoff

NGS and precision oncology in Australia: insights from Profs Peter Gibbs and Svetlana Cherepanoff

This article is part of a series of case studies on the use of NGS and digital tools to drive precision oncology in the Asia Pacific region. Scroll to the bottom of the article for the full list. In 2018, the Australian government committed $500 million over 10 years for genomic research. With the vast

NGS and precision oncology in Australia: insights from Profs Peter Gibbs and Svetlana Cherepanoff Read More »

Scroll to Top